• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮细胞在 COVID-19 中的作用。

The Role of Endothelium in COVID-19.

机构信息

Cardiology Department, Faculty of Medicine, Ovidius University of Constanţa, 900527 Constanţa, Romania.

Diabetes, Nutrition, and Metabolic Diseases Department, Faculty of Medicine, Carol Davila University, 050474 Bucharest, Romania.

出版信息

Int J Mol Sci. 2021 Nov 3;22(21):11920. doi: 10.3390/ijms222111920.

DOI:10.3390/ijms222111920
PMID:34769350
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8584762/
Abstract

The 2019 novel coronavirus, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), is causing a global pandemic. The virus primarily affects the upper and lower respiratory tracts and raises the risk of a variety of non-pulmonary consequences, the most severe and possibly fatal of which are cardiovascular problems. Data show that almost one-third of the patients with a moderate or severe form of COVID-19 had preexisting cardiovascular comorbidities such as diabetes mellitus, obesity, hypertension, heart failure, or coronary artery disease. SARS-CoV2 causes hyper inflammation, hypoxia, apoptosis, and a renin-angiotensin system imbalance in a variety of cell types, primarily endothelial cells. Profound endothelial dysfunction associated with COVID-19 can be the cause of impaired organ perfusion that may generate acute myocardial injury, renal failure, and a procoagulant state resulting in thromboembolic events. We discuss the most recent results on the involvement of endothelial dysfunction in the pathogenesis of COVID-19 in patients with cardiometabolic diseases in this review. We also provide insights on treatments that may reduce the severity of this viral infection.

摘要

2019 年新型冠状病毒,又称严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)或 2019 年冠状病毒病(COVID-19),正在引发全球大流行。该病毒主要影响上呼吸道和下呼吸道,并增加了多种非肺部后果的风险,其中最严重且可能致命的是心血管问题。数据表明,几乎三分之一患有中度或重度 COVID-19 的患者存在先前存在的心血管合并症,如糖尿病、肥胖症、高血压、心力衰竭或冠状动脉疾病。SARS-CoV2 在多种细胞类型中引起过度炎症、缺氧、细胞凋亡和肾素-血管紧张素系统失衡,主要是内皮细胞。与 COVID-19 相关的严重内皮功能障碍可能是导致器官灌注受损的原因,从而导致急性心肌损伤、肾衰竭和促凝状态导致血栓栓塞事件。在本综述中,我们讨论了内皮功能障碍在患有代谢性心血管疾病的 COVID-19 患者发病机制中的最新研究结果。我们还提供了可能降低这种病毒感染严重程度的治疗方法的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/881a/8584762/7d8326580688/ijms-22-11920-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/881a/8584762/26efd4f5e40e/ijms-22-11920-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/881a/8584762/7d8326580688/ijms-22-11920-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/881a/8584762/26efd4f5e40e/ijms-22-11920-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/881a/8584762/7d8326580688/ijms-22-11920-g002.jpg

相似文献

1
The Role of Endothelium in COVID-19.内皮细胞在 COVID-19 中的作用。
Int J Mol Sci. 2021 Nov 3;22(21):11920. doi: 10.3390/ijms222111920.
2
"When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review.SARS-CoV-2 感染的“何时”“何地”和“如何”影响人体心血管系统:叙述性综述。
Balkan Med J. 2024 Jan 3;41(1):7-22. doi: 10.4274/balkanmedj.galenos.2023.2023-10-25.
3
Endothelial dysfunction in COVID-19: Current findings and therapeutic implications.COVID-19 中的血管内皮功能障碍:当前研究结果及治疗意义。
Atherosclerosis. 2020 Dec;314:58-62. doi: 10.1016/j.atherosclerosis.2020.10.014. Epub 2020 Oct 14.
4
Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.α-硫辛酸对抗 COVID-19 感染期间心血管疾病的作用机制。
Int J Mol Sci. 2021 Jul 26;22(15):7979. doi: 10.3390/ijms22157979.
5
The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries.新型冠状病毒(SARS-CoV-2)感染对心血管疾病和心肺损伤的影响。
Stem Cell Res. 2021 Mar;51:102168. doi: 10.1016/j.scr.2021.102168. Epub 2021 Jan 12.
6
COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network.COVID-19 与高血压的证据与实践管理:HOPE 亚洲网络的指导建议。
J Clin Hypertens (Greenwich). 2020 Jul;22(7):1109-1119. doi: 10.1111/jch.13917. Epub 2020 Jul 9.
7
The Contribution of Endothelial Dysfunction in Systemic Injury Subsequent to SARS-Cov-2 Infection.内皮功能障碍在 SARS-CoV-2 感染后继发全身损伤中的作用。
Int J Mol Sci. 2020 Dec 6;21(23):9309. doi: 10.3390/ijms21239309.
8
Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.SARS-CoV-2 对血管内皮的感染和调控:COVID-19 中的证据和注意事项。
Viruses. 2020 Dec 26;13(1):29. doi: 10.3390/v13010029.
9
Coronary microvascular dysfunction pathophysiology in COVID-19.新型冠状病毒肺炎相关的冠状动脉微血管功能障碍的病理生理学
Microcirculation. 2021 Oct;28(7):e12718. doi: 10.1111/micc.12718. Epub 2021 Jun 2.
10
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.

引用本文的文献

1
Protein C Pretreatment Protects Endothelial Cells from SARS-CoV-2-Induced Activation.蛋白 C 预处理可保护血管内皮细胞免受 SARS-CoV-2 诱导的激活。
Viruses. 2024 Jun 28;16(7):1049. doi: 10.3390/v16071049.
2
Substance P - a regulatory peptide with defense and repair functions. Results and perspectives for the fight against COVID-19.P物质——一种具有防御和修复功能的调节肽。抗击新冠疫情的成果与展望。
Front Neurol. 2024 May 30;15:1370454. doi: 10.3389/fneur.2024.1370454. eCollection 2024.
3
The Review of Ophthalmic Symptoms in COVID-19.新型冠状病毒肺炎的眼部症状综述

本文引用的文献

1
The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells.SARS-CoV-2 刺突蛋白亚单位 S1 在 Κ18-hACE2 转基因小鼠中诱导 COVID-19 样急性肺损伤,并在人内皮细胞中引起屏障功能障碍。
Am J Physiol Lung Cell Mol Physiol. 2021 Aug 1;321(2):L477-L484. doi: 10.1152/ajplung.00223.2021. Epub 2021 Jun 22.
2
Post-Acute COVID-19 Neurological Syndrome: A New Medical Challenge.新冠后急性神经综合征:一项新的医学挑战。
J Clin Med. 2021 May 1;10(9):1947. doi: 10.3390/jcm10091947.
3
Long-Term Brain Disorders in Post Covid-19 Neurological Syndrome (PCNS) Patient.
Clin Ophthalmol. 2024 May 23;18:1417-1432. doi: 10.2147/OPTH.S460224. eCollection 2024.
4
Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?SGLT2 抑制剂为何未能在 COVID-19 中取得预期的成功?
Curr Pharm Des. 2024;30(15):1149-1156. doi: 10.2174/0113816128300162240322075423.
5
Can Global Longitudinal Strain Assess Asymptomatic Subtle Left Ventricular Dysfunction in Recovered COVID-19 Patients?全球纵向应变能否评估康复的新冠肺炎患者无症状的轻微左心室功能障碍?
J Cardiovasc Echogr. 2023 Oct-Dec;33(4):183-188. doi: 10.4103/jcecho.jcecho_6_23. Epub 2024 Feb 26.
6
Molecular cross-talk between long COVID-19 and Alzheimer's disease.长新冠与阿尔茨海默病之间的分子串扰。
Geroscience. 2024 Jun;46(3):2885-2899. doi: 10.1007/s11357-024-01096-1. Epub 2024 Feb 23.
7
Predictive Factors for Difficult Laparoscopic Cholecystectomies in Acute Cholecystitis.急性胆囊炎腹腔镜胆囊切除术困难的预测因素
Diagnostics (Basel). 2024 Feb 5;14(3):346. doi: 10.3390/diagnostics14030346.
8
Association Between Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) With Diabetic Retinopathy in Type 2 Diabetic Patients.2型糖尿病患者中性粒细胞与淋巴细胞比值(NLR)及血小板与淋巴细胞比值(PLR)与糖尿病视网膜病变的关系
Cureus. 2023 Nov 9;15(11):e48581. doi: 10.7759/cureus.48581. eCollection 2023 Nov.
9
Role of endothelial cells and angiotensin converting enzyme-II in COVID-19 and brain damages post-infection.内皮细胞和血管紧张素转换酶-II在COVID-19及感染后脑损伤中的作用。
Front Neurol. 2023 Jun 30;14:1210194. doi: 10.3389/fneur.2023.1210194. eCollection 2023.
10
Implantation of engineered human microvasculature to study human infectious diseases in mouse models.植入工程化人类微血管以在小鼠模型中研究人类传染病
iScience. 2023 Feb 27;26(4):106286. doi: 10.1016/j.isci.2023.106286. eCollection 2023 Apr 21.
新冠后神经综合征(PCNS)患者的长期脑部疾病
Brain Sci. 2021 Apr 2;11(4):454. doi: 10.3390/brainsci11040454.
4
Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study.死于 SARS-CoV-2:罗马尼亚 COVID-19 多中心合并症研究。
Sci Rep. 2020 Dec 10;10(1):21613. doi: 10.1038/s41598-020-78575-w.
5
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect.在2型糖尿病患者的真实世界中,利拉鲁肽通过降低小而密低密度脂蛋白来减少颈动脉内膜中层厚度:一种新的抗动脉粥样硬化作用。
Diabetes Ther. 2021 Jan;12(1):261-274. doi: 10.1007/s13300-020-00962-3. Epub 2020 Nov 18.
6
COVID-19 is, in the end, an endothelial disease.COVID-19 归根结底是一种血管内皮疾病。
Eur Heart J. 2020 Sep 1;41(32):3038-3044. doi: 10.1093/eurheartj/ehaa623.
7
COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?新型冠状病毒肺炎与心血管后果:内皮功能障碍是最严峻的挑战吗?
Thromb Res. 2020 Dec;196:143-151. doi: 10.1016/j.thromres.2020.08.039. Epub 2020 Aug 27.
8
Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses.新型冠状病毒病中的血管内皮功能障碍:冠状病毒带来的启示。
Curr Hypertens Rep. 2020 Aug 27;22(9):63. doi: 10.1007/s11906-020-01078-6.
9
Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology.2019冠状病毒病大流行期间心血管疾病患者及高危患者的连续性照护与门诊管理:美国预防心脏病学会的科学声明
Am J Prev Cardiol. 2020 Mar;1:100009. doi: 10.1016/j.ajpc.2020.100009. Epub 2020 May 1.
10
Issues for the management of people with diabetes and COVID-19 in ICU.ICU 中合并 COVID-19 的糖尿病患者的管理问题。
Cardiovasc Diabetol. 2020 Jul 20;19(1):114. doi: 10.1186/s12933-020-01089-2.